Ciplamed.com Website Review

a recent retrospective study an*lysed the operative outcomes after laparoscopic splenectomy (ls) and studied the effect of use of. bariatric surgery, relatively safe and effective in cirrhotic patients with portal hypertension. in a recent retrospective an*lysis of cirrhotic patients with portal hypertension undergoing bariatric surgery showed that laparoscopic. comparison of efficacy and safety of different types of inhalers for copd: a meta-an*lysis. a recent review and meta-an*lysis of trials evaluated the efficacy and safety of available formulations from four different groups of. better improvement in taste functions with allergen immunotherapy than intranasal steroids in allergic rhinitis patients. a recent prospective study demonstrated a better improvement in the taste function with subcutaneous allergen immunotherapy than opening the pandora’s box of challenging and fascinating cases – management of endometriosis grand round – case-based discussion on management of heavy menstrual bleeding this trial compares the safety and efficacy of taf vs tdf co-formulated with elvitegravir, cobicistat, and emtricitabine, for. enzalutamide and abiraterone improved survival outcomes in patients with metastatic castra.. enzalutamide was the most effective in prolonging the progression-free survival,  followed by abiraterone and tasquinimod in patients. oral dimethyl fumarate-a potential initial treatment for relapsing-remitting multiple scle.. oral dimethyl fumarate is a potential initial treatment for relapsing-remitting multiple sclerosis, as per the findings of the. surfactant therapy using insure method in management of respiratory distress syndrome. the best respiratory management for preterm infants remains a controversial issue. due to adverse effects of mechanical ventilation, this slide set covers basic understanding of probiotics and mechanism of action focussing on lactobacillus rhamnosus gg strain.   treatment for chronic constipation has evolved with the advent of newer targeted therapies. prucalopride is the first, selective and